Landmark Alzheimer ' s Prevention Trial Unable to Show Significantly Slower Cognitive Decline in Inherited Form of Disease

PHOENIX, June 16, 2022. A precedent-setting prevention trial in Colombia has found that the investigational medicine crenezumab did not slow or prevent decline in cognition or memory for cognitively healthy people with a rare genetic mutation that...
Source: Drugs.com - Clinical Trials - Category: Pharmaceuticals Source Type: clinical trials